Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carter
CRB-701-01, NCT06265727: A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors	Recruiting	1/2	420	Europe, US, RoW	CRB-701	Corbus Pharmaceuticals Inc., CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.	Solid Tumor, Adult	01/27	01/27
NCT05462860: Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds	Recruiting	N/A	21	US	Suprathel®, standard of care	The Metis Foundation	Wound of Skin, Burns	09/25	09/25